Showing 1,450 news articles about Pharmaceutical industry

Filters Content type: Editors' picks Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

Access to healthcare

SOUTH AFRICA: New ARV tender drops prices, changes treatment

Editor's pick
IRIN Plus News
30 November 2012
Access to healthcare

Canada: Tories block bid to make cheaper medicines for poorer nations

Editor's pick
Globe and Mail
30 November 2012
Finance & funding

South Africa: Country Saves R2.2 Billion in HIV Drug Tender

Editor's pick
AllAfrica
30 November 2012
Starting treatment

South Africa: HIV Patients to Take One ARV Tablet Daily

Editor's pick
AllAfrica
30 November 2012
Access to healthcare

J&J Won't Enforce Patents on HIV Medicine in Africa

Editor's pick
Bloomberg BusinessWeek
30 November 2012
Access to healthcare

Patients in Control demanded a two-fold reduction of the price for Kaletra in Russia

Editor's pick
EATG
30 November 2012
Pharmaceutical industry

South Africa awards $667 million HIV drugs supply contract

Editor's pick
Reuters
29 November 2012
Access to healthcare

GSK heads pharma table for access to medicine for poor

Editor's pick
Pharma Times
29 November 2012
Clinical trials

As drug industry’s influence over research grows, so does the potential for bias

Editor's pick
Washington Post
26 November 2012
Pharmaceutical industry

Doctors tread warily over insider trading

Editor's pick
Financial Times
24 November 2012
New & experimental hepatitis C treatment

Copy of New second generation combination therapy for HCV - first or best in the market

Editor's pick
Seeking Alpha
19 November 2012
New & experimental hepatitis C treatment

New second generation combination therapy for HCV - first or best in the market

Editor's pick
Seeking Alpha
19 November 2012
New & experimental HIV treatments

Merck & Co and Gilead highlight new data at international HIV meeting

Editor's pick
The Pharma Letter
16 November 2012
Pharmaceutical industry

Drug pricing must remain "absolute domain" of companies, says ABPI

Editor's pick
Pharma Times
15 November 2012
New & experimental hepatitis C treatment

Gilead may move ahead of rivals with hepatitis C results

Editor's pick
Bloomberg Businessweek
15 November 2012
New & experimental hepatitis C treatment

Copy of Gilead may move ahead of rivals with hepatitis C results

Editor's pick
Bloomberg Businessweek
15 November 2012
Pharmaceutical industry

Row flares over global fight against fake medicine

Editor's pick
Reuters
15 November 2012
New & experimental hepatitis C treatment

Gilead, Abbott Unwrap Dueling Hep C Pill Data

Editor's pick
The Street
12 November 2012
Access to healthcare

Study shows drug patents can be extended for decades

Editor's pick
Intellectual Property Watch
12 November 2012
New & experimental hepatitis C treatment

Boehringer Ingelheim to start late-stage hepatitis C drug trial

Editor's pick
Reuters
11 November 2012
New & experimental hepatitis C treatment

Idenix Reports On IDX719 and IDX184

Editor's pick
Idenix press release
11 November 2012
Pharmaceutical industry

Drugmakers offer to cap Greece's medicines bill

Editor's pick
Reuters
8 November 2012
Pharmaceutical industry

Gilead's Stribild to reinforce HIV/AIDS revenues as key patents expire

Editor's pick
The Pharma Letter
8 November 2012
New & experimental hepatitis C treatment

Copy of Merck will initiate interferon-free Phase II clinical trials for MK-5172, an investigational, once-daily, oral treatment for chronic hepatitis C virus

Editor's pick
Merck press release
6 November 2012